呼吸道合胞病毒减毒活疫苗 (Sanofi Pasteur): 一种免疫刺激剂药物,由Sanofi (Sanofi)公司最早进行研发,目前全球最高研发状态为临床3期,作用机制: 免疫刺激剂,治疗领域: 感染,在研适应症: 呼吸道合胞体病毒感染,在研机构: Sanofi Pasteur。
Sanofi Pasteur has provided 6 million doses of yellow fever vaccine to assist in combating an epidemic of the disease in Latin America. In response to requests from UNICEF , the company dispatched 4 million doses to Brazil in early February and an extra 2 million doses to Paraguay more ...
Learn about rabies, its symptoms, and the importance of the rabies vaccine. Discover how Sanofi's innovative vaccines prevent rabies effectively.
药物总览提供了狂犬病疫苗(赛诺菲巴斯德)Rabies vaccine (Sanofi Pasteur)相关药品信息, 涵盖了药品临床前,临床阶段,注册,上市等药品全生命周期研发数据, 通过表格与图表等形式多维度地帮助帮助用户筛选与查看
Safety and Immunogenicity of an Investigational Multicomponent Meningococcal Group B Vaccine in Adults, Adolescents, Toddlers, and Infants 开始日期- 申办/合作机构 Sanofi Pasteur, Inc. NCT06128733 /Active, not recruiting临床1/2期 A Phase I/II, Randomized, Descriptive, Safety and Immunogenicity Study to...
Thomas Triomphe--Executive Vice President, Sanofi Pasteur No, I can't say the other one. Thanks for the question, Richard. Very good point indeed. A few first points to start with. First of all, there's still a lot to go in terms of monoclonal antibody penetration. So we really welcom...
A candidate tetravalent (TV) dengue vaccine based on the yellow fever (YF) 17D vaccine has been developed by sanofi pasteur. This dengue TV vaccine induced a controlled dendritic cell stimulation in vitro. In clinical trials, Th1 and CD8 responses were induced with an IFN-γ/TNF-α ratio fa...
原料品名 hepatitis B vaccine, (recombinant) 供应商信息 企业名称 Sanofi Pasteur 备注 若未能联系上供应商,可在药智通发布求购信息(https://s.yaozh.com/Purchase/release),或联系药智通客服17318480790(微信同号) 扩展信息 VIP试用医疗器械查询APP下载客服中心常见问题数据可视化数据分析挖掘系统网站地图...
An employee working on a vaccine assembly line in Sanofi Pasteur’s vaccine production facility outside Lyon. Philippe Desmazes—AFP/Getty Images Viehbacher himself symbolized change. The German-born Canadian was the first non-Frenchman to helm the company (which this year rankedNo. 288on theFortu...
Sanofi Pasteur has developed a recombinant, live-attenuated, tetravalent dengue vaccine (CYD-TDV) that is in late-stage development. The present review summarizes the different steps in the development of this dengue vaccine, with a particular focus on the clinical data from three efficacy trials,...